ALEXION PHARMACEUTICALS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Net product sales
Revenues
Product
Net Product Sales
Other revenue
Total revenues
Costs and expenses:
Cost of sales (exclusive of amortization of purchased intangible assets)
Research and development
Research and development
Selling, general and administrative
Acquired in-process research and development
Amortization of purchased intangible assets
Change in fair value of contingent consideration
Acquisition-related costs
Restructuring expenses
Impairment of intangible assets
Total operating expenses
Gain on sale of asset
Total costs and expenses
Operating income
Other income and expense:
Investment income, net
Interest expense
Other income (expense)
Other income and (expense)
Income before income taxes
Income tax (benefit) expense
Net income
Earnings per common share
Basic (in dollars per share)
Diluted (in dollars per share)
Shares used in computing earnings per common share
Basic (in shares)
Diluted (in shares)

Comments